4//SEC Filing
Arix Bioscience plc 4
Accession 0000899243-19-028848
CIK 0001708493other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 7:27 PM ET
Size
11.9 KB
Accession
0000899243-19-028848
Insider Transaction Report
Form 4
Arix Bioscience Holdings Ltd
10% Owner
Transactions
- Sale
Common stock
2019-12-09$18.12/sh−77,316$1,400,664→ 2,740,613 total(indirect: See Footnote) - Sale
Common stock
2019-12-10$16.91/sh−131,696$2,227,019→ 2,608,917 total(indirect: See Footnote) - Sale
Common stock
2019-12-06$19.15/sh−47,752$914,222→ 2,844,367 total(indirect: See Footnote) - Sale
Common stock
2019-12-09$18.30/sh−26,438$483,781→ 2,817,929 total(indirect: See Footnote)
Arix Bioscience plc
10% Owner
Transactions
- Sale
Common stock
2019-12-06$19.15/sh−47,752$914,222→ 2,844,367 total(indirect: See Footnote) - Sale
Common stock
2019-12-09$18.30/sh−26,438$483,781→ 2,817,929 total(indirect: See Footnote) - Sale
Common stock
2019-12-09$18.12/sh−77,316$1,400,664→ 2,740,613 total(indirect: See Footnote) - Sale
Common stock
2019-12-10$16.91/sh−131,696$2,227,019→ 2,608,917 total(indirect: See Footnote)
Footnotes (1)
- [F1]These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001700449
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 7:27 PM ET
- Size
- 11.9 KB